銵?鋆蔭?詨
ABOUT US
PIPELINE
LBS-008
LBS-009
LBS-007
LBS-002
MEDIA & PUBLICATION
NEWS
PUBLICATION
INVESTORS
EVENTS & PRESENTATION
INVESTOR CONFERENCE
Financial Information
Corporate Governance
CONTACT US
ABOUT US
PIPELINE
LBS-008
LBS-009
LBS-007
LBS-002
MEDIA & PUBLICATION
NEWS
PUBLICATION
INVESTORS
Events & Presentation
Investor Conference
Financial Information
Corporate Governance
CONTACT US
MEDIA & PUBLICATION
HOME
MEDIA & PUBLICATION
NEWS
NEWS
PUBLICATION
NEWS
Lin BioScience Receives EMA Orphan Drug Status for LBS-008 for the Treatment of Stargardt Disease
Jun 28 , 2018
Lin BioScience Announces FDA Orphan Drug Designation for LBS-007 for the Treatment of Acute Lymphoblastic Leukemia
Apr 25 , 2018
Researchers Discover Potential Treatment For Stargardt Disease
Apr 17 , 2018
NIH Translational Research Success Stories - LBS-008
Mar 09 , 2018
Lin BioScience to Present Highlights for Phase I Clinical Candidates for the Treatment of Macular Degeneration and Cancer at the Biotech Showcase™ Annual Conference on January 10, 2018
Jan 10 , 2018
1
2
3
4
Subscribe
Subscribe Newsletter
submit
unsubscribe